Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 1Biophore India Pharmaceuticals Pvt Ltd
02 1Sanofi
03 1ACIC Europe API & Pharmaceuticals
04 1American Chemical Products
05 1Emcure Pharmaceuticals
06 1Lonza Group
07 1Merck & Co
08 1Raks Pharma
09 1SKVen Technologies Pvt. Ltd
10 1Trifarma
01 1Cyprus
02 1France
03 4India
04 1Italy
05 1Switzerland
06 2U.S.A
01 4Active
02 5Inactive
03 1Blank
01 10Blank
01 10Blank
01 1WC-0226
02 9Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-11-29
Pay. Date : 2017-11-06
DMF Number : 32178
Submission : 2017-10-31
Status : Active
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3545
Submission : 1979-05-25
Status : Inactive
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-15
Pay. Date : 2016-12-28
DMF Number : 31176
Submission : 2016-12-26
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
NDC Package Code : 14593-918
Start Marketing Date : 2022-02-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-05-10
Pay. Date : 2019-03-26
DMF Number : 33693
Submission : 2019-03-28
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-10-26
Pay. Date : 2012-11-14
DMF Number : 16055
Submission : 2002-07-19
Status : Active
Type : II
NDC Package Code : 46204-0121
Start Marketing Date : 2012-08-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2882
Submission : 1977-03-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4302
Submission : 1981-10-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5425
Submission : 1984-01-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5941
Submission : 1985-06-26
Status : Inactive
Type : II
A Prochlorperazine Edisylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prochlorperazine Edisylate, including repackagers and relabelers. The FDA regulates Prochlorperazine Edisylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prochlorperazine Edisylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prochlorperazine Edisylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prochlorperazine Edisylate supplier is an individual or a company that provides Prochlorperazine Edisylate active pharmaceutical ingredient (API) or Prochlorperazine Edisylate finished formulations upon request. The Prochlorperazine Edisylate suppliers may include Prochlorperazine Edisylate API manufacturers, exporters, distributors and traders.
click here to find a list of Prochlorperazine Edisylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 10 companies offering Prochlorperazine Edisylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?